No Data
Citi Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Cuts Target Price to $44
Phibro Animal Health Price Target Lowered to $44 From $62 at Citi
Phibro Animal Health Corporation (PAHC) Announces Financial Results for Q3
Phibro Outlines FY2026 Net Sales of $1.46B-$1.5B as Adjusted EBITDA Guidance Moves to $247M-$255M
Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference
Phibro Animal Health Down Over 21%, On Pace for Largest Percent Decrease Since August 2019 -- Data Talk